High Expression of Cystine-Glutamate antiporter XCT (SLC7A11) is an independent biomarker for epileptic seizures at diagnosis in glioma

Christoph Patrick Beier, Sólborg Berglind Heimisdóttir, Helle Wohlleben, Bjarne Winther Kristensen

Research output: Contribution to conference without publisher/journalConference abstract for conferenceResearch

Original languageEnglish
Publication date2. Sep 2017
Publication statusPublished - 2. Sep 2017
EventCT 32nd International Epilepsi Congress - Barcelona, Barcelona, Spain
Duration: 2. Sep 20176. Sep 2017

Conference

ConferenceCT 32nd International Epilepsi Congress
LocationBarcelona
CountrySpain
CityBarcelona
Period02/09/201706/09/2017

Cite this